Related Experiment Video
Updated: Jun 22, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
Published on: March 3, 2021
FOG: Fragment Optimized Growth algorithm for the de novo generation of molecules occupying druglike chemical space
Peter S Kutchukian1, David Lou, Eugene I Shakhnovich
1Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA.
Abstract:
An essential feature of all practical de novo molecule generating programs is the ability to focus the potential combinatorial explosion of grown molecules on a desired chemical space. It is a daunting task to balance the generation of new molecules with limitations on growth that produce desired features such as stability in water, synthetic accessibility, or drug-likeness. We have developed an algorithm, Fragment Optimized Growth (FOG), which statistically biases the growth of molecules with desired features. At the heart of the algorithm is a Markov Chain which adds fragments to the nascent molecule in a biased manner, depending on the frequency of specific fragment-fragment connections in the database of chemicals it was trained on. We show that in addition to generating synthetically feasible molecules, it can be trained to grow new molecules that resemble desired classes of molecules such as drugs, natural products, and diversity-oriented synthetic products. In order to classify our grown molecules, we developed the Topology Classifier (TopClass) algorithm that is capable of classifying compounds, for example as drugs or nondrugs. The classification accuracies obtained with TopClass compare favorably with the literature. Furthermore, in contrast to "black-box" approaches such as Neural Networks, TopClass brings to light characteristics of drugs that distinguish them from nondrugs.
Related Concept Videos
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Ziegler–Natta Chain-Growth Polymerization: Overview
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Lagging Strand Synthesis
There are several major differences between synthesis of the leading strand and synthesis of the lagging strand. 1) Leading strand synthesis happens in the direction of replication fork opening, whereas lagging strand synthesis happens in the...

